Tivic reports first quarter 2025 financial results and provides updates on business transformation

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a diversified immunotherapeutics company, today announced financial results for the first quarter ended march 31, 2025 and outlined operational highlights based on its newly expanded clinical pipeline. “this is a defining time for the company. during the quarter we initiated a significant strategic shift, dramatically expanding tivic's clinical pipeline for restoring immune system health," stated tivic ceo jennifer er.
TIVC Ratings Summary
TIVC Quant Ranking